概要
As a direct and sole result of the outbreak of the coronavirus disease (COVID-19) and due to circumstances beyond our control, DIA has decided to change the format of the upcoming Advertising and Promotion Regulatory Affairs Conference from "face-to-face" (in-person) to entirely virtual.
For more information, please review the list of Frequently Asked Questions
DIA's Advertising and Promotion Regulatory Affairs Conference explores the current state of compliance for marketing both biopharmaceuticals and medical devices. Join thought leaders from industry, legal, public affairs, and government for interactive and compelling discussions that will shape policy and define strategic priorities within the advertising and promotion regulatory space. Representatives from across FDA’s Medical Product Offices will provide the latest information on guidance policies, enforcement actions, and future directions of industry hot topics such as pre-approval activities, labeling strategies, and social media tactics.
This conference is geared towards both early and late-career professionals with content that advances the understanding of current regulatory policies, details the latest strategies for effective patient engagement, and discusses the trends in advertising for biopharmaceuticals, combo products and companion diagnostics. Attendees will have the opportunity to network with key thought leaders from the FDA, industry, and other regulatory practitioners, while simultaneously discussing the challenges and opportunities of marketing pharmaceuticals and medical devices today.
Featured
Want to learn more about Advertising and Promotion Regulatory Affairs Conference? You've come to the right site!
プログラム委員会
-
Micheline Awad, MBA Sr. Director, Regulatory Advertising, Promotion, and Labeling
Day One Biopharmaceuticals, United States -
Kimberly Belsky, MS Reg Policy & Intell and AdPromo, Regulatory Affairs
Independent, United States -
Glenn N. Byrd, MBA President
GByrd Ad-Promo Solutions, LLC, United States -
Dale Cooke, JD, MA President
PhillyCooke Consulting , United States -
Mark Gaydos Global Head, Advertising & Promotion, Global Regulatory Affairs
Sanofi, United States -
Joanne Hawana, JD, MS Member
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo P.C., United States -
Mary L Raber Johnson, PhD, RAC Assistant Professor - Clinical
The Ohio State University, College of Pharmacy, United States -
Kevin Madagan, JD Partner
Reed Smith, LLP, United States -
Sheetal Patel, PharmD Vice President, Specialty Compliance
Johnson & Johnson, United States -
Victoria Tamarkin, MS Founding Partner & President, Global Regulatory Affairs, Promotional Compliance
Victoria Tamarkin Consulting LLC, United States -
Thomas W. Abrams, MBA, RPh Retired, Director, Office of Prescription Drug Promotion, OMP, CDER
Former FDA, United States -
Wayne Pines President, Health Care
United States -
Lucy Rose, MBA President
Lucy Rose and Associates, United States